Texas 2015 - 84th Regular

Texas Senate Bill SB66 Latest Draft

Bill / House Committee Report Version Filed 02/01/2025

Download
.pdf .doc .html
                            By: Hinojosa S.B. No. 66
 (Crownover, Herrero)


 A BILL TO BE ENTITLED
 AN ACT
 relating to the use of epinephrine auto-injectors on public school
 and open-enrollment charter school campuses and at or in transit to
 or from off-campus school events.
 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
 SECTION 1.  This Act shall be known as the Cameron Espinosa
 Act.
 SECTION 2.  Chapter 38, Education Code, is amended by adding
 Subchapter E to read as follows:
 SUBCHAPTER E.  MAINTENANCE AND ADMINISTRATION OF EPINEPHRINE
 AUTO-INJECTORS
 Sec. 38.201.  DEFINITIONS.  In this subchapter:
 (1)  "Advisory committee" means the committee
 established under Section 38.202.
 (2)  "Anaphylaxis" means a sudden, severe, and
 potentially life-threatening allergic reaction that occurs when a
 person is exposed to an allergen.
 (3)  "Epinephrine auto-injector" means a disposable
 medical drug delivery device that contains a premeasured single
 dose of epinephrine that is intended to be used to treat
 anaphylaxis.
 (4)  "Physician" means a person who holds a license to
 practice medicine in this state.
 Sec. 38.202.  ADVISORY COMMITTEE:  ESTABLISHMENT AND
 COMPOSITION.  (a)  The commissioner of state health services shall
 establish an advisory committee to examine and review:
 (1)  the administration of epinephrine auto-injectors
 on a person experiencing an anaphylactic reaction on a campus of a
 school district or an open-enrollment charter school or at or in
 transit to or from an off-campus school event; and
 (2)  the maintenance and disposal of epinephrine
 auto-injectors by a school district or an open-enrollment charter
 school.
 (b)  The advisory committee shall be composed of members
 appointed by the commissioner of state health services. In making
 appointments, the commissioner shall ensure that:
 (1)  a majority of the members are physicians with
 expertise in treating anaphylaxis, including physicians who
 specialize in the fields of pediatrics, allergies, asthma, and
 immunology; and
 (2)  at least one member is a registered nurse employed
 by a school district or open-enrollment charter school as a school
 nurse.
 (c)  A member of the advisory committee serves at the
 pleasure of the commissioner of state health services.
 (d)  A vacancy on the advisory committee is filled by the
 commissioner of state health services in the same manner as other
 appointments to the advisory committee.
 Sec. 38.203.  ADVISORY COMMITTEE: PRESIDING OFFICER.  The
 advisory committee shall elect a presiding officer.
 Sec. 38.204.  ADVISORY COMMITTEE: COMPENSATION AND
 EXPENSES.  Members of the advisory committee serve without
 compensation but are entitled to reimbursement for travel expenses.
 Sec. 38.205.  ADVISORY COMMITTEE:  APPLICABILITY OF OTHER
 LAW.  Chapter 2110, Government Code, does not apply to the advisory
 committee.
 Sec. 38.206.  ADVISORY COMMITTEE:  OPEN MEETINGS.  Meetings
 of the advisory committee are subject to Chapter 551, Government
 Code.
 Sec. 38.207.  ADVISORY COMMITTEE: DUTIES.  The advisory
 committee shall advise the commissioner of state health services
 on:
 (1)  the storage of epinephrine auto-injectors on
 school campuses;
 (2)  the maintenance of epinephrine auto-injectors
 while in transit to or from an off-campus school event;
 (3)  the training of school personnel in the
 administration of an epinephrine auto-injector; and
 (4)  a plan for one or more school personnel members
 trained in the administration of an epinephrine auto-injector to be
 on each school campus.
 Sec. 38.208.  MAINTENANCE AND ADMINISTRATION OF EPINEPHRINE
 AUTO-INJECTORS.  (a)  Each school district and open-enrollment
 charter school shall adopt and implement a policy requiring the
 maintenance, administration, and disposal of epinephrine
 auto-injectors at each campus in the district or school.
 (b)  The policy adopted under Subsection (a) must provide
 that school personnel who are authorized and trained may administer
 an epinephrine auto-injector to a person who is reasonably believed
 to be experiencing anaphylaxis on a school campus or at an
 off-campus school event.
 (c)  The commissioner of state health services, in
 consultation with the commissioner of education, and with advice
 from the advisory committee, shall adopt rules regarding the
 maintenance, administration, and disposal of an epinephrine
 auto-injector at a school campus or while students are at an
 off-campus school event or in transit to or from an off-campus
 school event.  The rules must establish:
 (1)  the number of epinephrine auto-injectors
 available:
 (A)  at each campus; and
 (B)  while students are at an off-campus school
 event or in transit to or from an off-campus school event;
 (2)  the process for each school district and
 open-enrollment charter school to check the inventory of
 epinephrine auto-injectors at regular intervals for expiration and
 replacement; and
 (3)  the amount of training required for school
 personnel to administer an epinephrine auto-injector.
 (d)  Each school district and open-enrollment charter school
 must have a plan requiring that each campus have one or more school
 personnel members authorized and trained to administer an
 epinephrine auto-injector present during all hours the campus is
 open.
 (e)  The supply of epinephrine auto-injectors must:
 (1)  be stored in a secure location on campus and
 securely maintained while at an off-campus school event or in
 transit to or from an off-campus school event; and
 (2)  be easily accessible to school personnel
 authorized and trained to administer an epinephrine auto-injector.
 Sec. 38.209.  REPORT ON ADMINISTERING EPINEPHRINE
 AUTO-INJECTOR.  (a)  Not later than the 10th business day after the
 date a school personnel member administers an epinephrine
 auto-injector, the school shall report the information required
 under Subsection (b) to:
 (1)  the school district or the charter holder if the
 school is an open-enrollment charter school;
 (2)  the physician who prescribed the epinephrine
 auto-injector;
 (3)  the commissioner of education; and
 (4)  the commissioner of state health services.
 (b)  The report required under this section must include the
 following information:
 (1)  the age of the person who received the
 administration of the epinephrine auto-injector;
 (2)  whether the person who received the administration
 of the epinephrine auto-injector was a student, a school personnel
 member, or a visitor;
 (3)  the physical location where the epinephrine
 auto-injector was administered;
 (4)  the number of doses of epinephrine auto-injector
 administered;
 (5)  the title of the person who administered the
 epinephrine auto-injector; and
 (6)  any other information required by the commissioner
 of education.
 Sec. 38.210.  TRAINING. (a)  Each school district and
 open-enrollment charter school is responsible for training school
 personnel in the administration of an epinephrine auto-injector.
 (b)  Training required under this section must:
 (1)  include information on:
 (A)  recognizing the signs and symptoms of
 anaphylaxis;
 (B)  administering an epinephrine auto-injector;
 (C)  implementing emergency procedures, if
 necessary, after administering an epinephrine auto-injector; and
 (D)  properly disposing of used or expired
 epinephrine auto-injectors; and
 (2)  be provided in a formal training session or
 through online education and be completed annually.
 (c)  Each school district and open-enrollment charter school
 shall maintain records on the training required under this section.
 (d)  School personnel who have received training under this
 section, in accordance with the provisions of this subchapter, may:
 (1)  take an epinephrine auto-injector from a location
 described by Section 38.208(e)(1); and
 (2)  administer the epinephrine auto-injector.
 Sec. 38.211.  PRESCRIPTION OF EPINEPHRINE AUTO-INJECTORS.
 (a)  A physician may prescribe epinephrine auto-injectors in the
 name of a school district or open-enrollment charter school.
 (b)  The physician shall provide the school district or
 open-enrollment charter school with a standing order for the
 administration of an epinephrine auto-injector to a person
 reasonably believed to be experiencing anaphylaxis.
 (c)  The standing order under Subsection (b) is not required
 to be patient-specific, and the epinephrine auto-injector may be
 administered to a person without a previously established
 physician-patient relationship.
 (d)  Notwithstanding any other provisions of law,
 supervision or delegation by a physician is considered adequate if
 the physician:
 (1)  periodically reviews the order; and
 (2)  is available through direct telecommunication as
 needed for consultation, assistance, and direction.
 (e)  An order issued under this section must contain:
 (1)  the name and signature of the prescribing
 physician;
 (2)  the name of the school district or open-enrollment
 charter school to which the order is issued;
 (3)  the quantity of epinephrine auto-injectors to be
 obtained and maintained under the order; and
 (4)  the date of issue.
 (f)  A pharmacist may dispense an epinephrine auto-injector
 to a school district or open-enrollment charter school without
 requiring the name or any other identifying information relating to
 the user.
 Sec. 38.212.  FUNDING. (a)  A school district or
 open-enrollment charter school is required to comply with this
 subchapter only if sufficient funds are available.
 (b)  A school district or open-enrollment charter school may
 accept gifts, grants, donations, and federal and local funds to
 implement this subchapter.
 Sec. 38.213.  UNANTICIPATED LOSS OF EPINEPHRINE
 AUTO-INJECTORS.  If a school district or open-enrollment charter
 school cannot maintain an inventory of epinephrine auto-injectors
 because of a manufacturer's recall or any other unanticipated loss
 or reduction, the district or school is not required to comply with
 this subchapter.
 Sec. 38.214.  NOTICE TO PARENTS. (a)  Before each school
 year, a school district or open-enrollment charter school shall
 provide written notice to a parent or guardian of each student
 enrolled in the district or school stating whether the district or
 school will implement a policy under this subchapter for the
 maintenance, administration, and disposal of epinephrine
 auto-injectors.
 (b)  If a school district or open-enrollment charter school
 will implement a policy under this subchapter, the district or
 school must provide the notice required under Subsection (a) before
 implementing the policy.
 Sec. 38.215.  RULES. Except as otherwise provided by this
 subchapter, the commissioner of education and the commissioner of
 state health services shall jointly adopt rules necessary to
 implement this subchapter.
 Sec. 38.216.  IMMUNITY FROM LIABILITY. (a)  A person who in
 good faith takes, or fails to take, any action under this subchapter
 is immune from civil or criminal liability or disciplinary action
 resulting from that action or failure to act, including:
 (1)  issuing an order for epinephrine auto-injectors;
 (2)  supervising or delegating the administration of an
 epinephrine auto-injector;
 (3)  possessing, maintaining, or disposing of an
 epinephrine auto-injector;
 (4)  prescribing an epinephrine auto-injector;
 (5)  dispensing an epinephrine auto-injector;
 (6)  administering, or assisting in administering, an
 epinephrine auto-injector;
 (7)  providing, or assisting in providing, training,
 consultation, or advice in the development, adoption, or
 implementation of policies, guidelines, rules, or plans; or
 (8)  undertaking any other act permitted or required
 under this subchapter.
 (b)  The immunities and protections provided by this
 subchapter are in addition to other immunity or limitations of
 liability provided by law.
 (c)  Notwithstanding any other law, this subchapter does not
 create a civil, criminal, or administrative cause of action or
 liability or create a standard of care, obligation, or duty that
 provides a basis for a cause of action or liability.
 (d)  A cause of action does not arise from an act or omission
 described by this section.
 (e)  The immunities and protections provided by this
 subchapter shall continue in full force and effect, regardless of
 whether a school district or open-enrollment charter school is
 excused under Section 38.212 or 38.213 from complying with this
 subchapter.
 SECTION 3.  Section 38.0151, Education Code, is amended by
 adding Subsection (f) to read as follows:
 (f)  A school district or open-enrollment charter school
 that provides for the maintenance, administration, and disposal of
 epinephrine auto-injectors under Subchapter E is not required to
 comply with this section.
 SECTION 4.  This Act applies beginning with the 2015-2016
 school year.
 SECTION 5.  This Act takes effect immediately if it receives
 a vote of two-thirds of all the members elected to each house, as
 provided by Section 39, Article III, Texas Constitution.  If this
 Act does not receive the vote necessary for immediate effect, this
 Act takes effect September 1, 2015.